A new systematic review shows that any amount of running is associated with a 27% lower risk of death from all causes. Researchers conclude that greater participation in running—without needing to run far or fast—could substantially boost population health and longevity.
Prior research has hinted at running's potential to reduce all-cause mortality, especially from cardiovascular disease and cancer. Yet uncertainties remain about the optimal 'dose'—how much running is needed and whether ramping up frequency, duration, or pace delivers even greater benefits.
To clarify, researchers conducted a systematic review of published studies, conference abstracts, and dissertations from major academic databases, focusing on links between running or jogging and risks of all-cause mortality, cardiovascular disease, and cancer mortality.
They identified 14 high-quality studies tracking 232,149 participants over 5.5 to 35 years, during which 25,951 deaths occurred.
Pooling the data revealed that runners had a 27% lower risk of all-cause death compared to non-runners, a 30% reduction in cardiovascular mortality, and a 23% drop in cancer mortality—benefits seen in both men and women.
Even modest efforts—running once a week or less, for under 50 minutes at speeds below 5 mph—were tied to significant health gains, equivalent to far more walking than typical guidelines require.
This positions running as an efficient choice for time-strapped individuals seeking vigorous activity benefits.
However, greater running 'doses' did not further lower all-cause mortality risk in this analysis.
As an observational review, these findings show associations, not causation. Limitations include the small number of studies and methodological variations that could affect results.
Still, the evidence is compelling: “Increased participation rates in running, regardless of dose, would likely lead to substantial improvements in population health and longevity,” the researchers conclude.
